Alireza Andalib

Dr. Alireza Andalib


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Pathology - Research and Practice
Verified
Journal Article
Closed access
YMYaser Moghaddam
Yaser Moghaddam
AAAlireza Andalib
Alireza Andalib
MMMaryam Mohammad-Ganji
Maryam Mohammad-Ganji
VHVida Homayouni
Vida Homayouni
MSMohammadreza Sharifi
Mohammadreza Sharifi
MGMazdak Ganjalikhani-Hakemi
Mazdak Ganjalikhani-Hakemi

22 January 2020 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
RARazieh Alipour
Razieh Alipour
AFAlimohammad Fatemi
Alimohammad Fatemi
FAFereshteh Alsahebfosoul
Fereshteh Alsahebfosoul
AAAlireza Andalib
Alireza Andalib
APAbbasali Pourazar
Abbasali Pourazar
Objective: Currently, the replacement of fetal calf serum (FCS) by a more suitable alternative is a sought aim in the field of tissue and cell culture research. Autologous plasma (AP) and especially autologous serum (AS) have been shown to be effective substitutes of FCS in culture media for some of the cell types. Nevertheless, there is no comparative data on the most appropriate supplement for cell media in neutrophil studies, it is now unclear whether AP have a relatively equal, superior or inferior performance to FCS in neutrophil cell culture. In the present study, human blood neutrophils were isolated and cultured in FCS- or AP-supplemented medium. After 12, 36 and 60 h of incubation, cell viability, oxidative burst and CD11b expression were determined by flow cytometry.Results: Compared to the culture of neutrophils in FCS 10% medium, the culture of neutrophils in a medium with AP 10% could prolong their life span without affecting their function. The findings introduce AP as a better supplement for human neutrophil cell culture than FCS and propose a simple and economical procedure for neutrophil isolation and culture.

5 February 2021 in BMC Immunology
Verified
Journal Article
Open access
PDF file
AFAlimohammad Fatemi
Alimohammad Fatemi
RARazieh Alipour
Razieh Alipour
HKHossein Khanahmad
Hossein Khanahmad
FAFereshteh Alsahebfosoul
Fereshteh Alsahebfosoul
AAAlireza Andalib
Alireza Andalib
APAbbasali Pourazar
Abbasali Pourazar
Background: NET (neutrophil extracellular trap) has been shown to directly influence inflammation; in SLE (systemic lupus erythematosus), it is reportedly a plausible cause for the broken self-tolerance that contributes to this pathology. Meanwhile, the role of NET is not easily explicable, and there is a serious discrepancy in the role of NET in SLE pathology and generally inflammation; in particular, the interactions of neutrophils with NET have been rarely inspected. This study evaluates the effect of NET on neutrophils in the context of SLE. The neutrophils were incubated by the collected NET (from SLE patients and healthy controls) and their expression of an activation marker, viability and oxidative burst ability were measured. Results: The level of cell mortality, CD11b expression and the oxidative burst capacity were elevated in NET-treated neutrophils. Also, the elevation caused by the SLE NET was higher than that produced by the healthy NET. Conclusion: The decreased neutrophil viability was not due to the increase in apoptosis; rather, it was because of the augmentation of other inflammatory cell-death modes. The upregulation of CD11b implies that NET causes neutrophils to more actively contribute to inflammation. The increased oxidative burst capacity of neutrophils can play a double role in inflammation. Overall, the effects induced by NET on neutrophils help prolong inflammation; accordingly, the NET collected from SLE patients is stronger than the NET from healthy individuals.

1 March 2012
Verified
Journal Article
Closed access
SGSamira Ghorbani Gazar
Samira Ghorbani Gazar
AAAlireza Andalib
Alireza Andalib
MHMohamad Hashemi
Mohamad Hashemi
ARAbbas Rezaei
Abbas Rezaei

1 January 2013 in Advanced Biomedical Research
Verified
Journal Article
Open access
PDF file
AAAlireza Andalib
Alireza Andalib
HDHassan Doulabi
Hassan Doulabi
MMMohammadReza Maracy
MohammadReza Maracy
ARAbbas Rezaei
Abbas Rezaei
SHSeyedJavad Hasheminia
SeyedJavad Hasheminia
Background: CD4+(TH1, and TH2) cell groups in the point of view of chemokine receptor expression were considered in blood of stomach cancer patients. Materials and Methods: The percentage of blood CD4+ T cells expressing chemokine receptors (before and after gastrectomy) was determined by flow cytometry (Becton Dickinson, USA) using the following chemokine receptor antibodies: anti-CCR5, anti-CXCR3, anti-CCR3 and anti-CCR4. Results: The means of CD4 + CCR5 + expressing cells was 1.23% ± 0.90, 0.83% ± 0.34 and 1.34% ± 0.74 in control, pre- and post-operation groups, respectively. CD4 + CXCR3 + expressing cells were 19.09% ± 8.4, 16.95% ± 5.71 and 25.08% ± 9.31, respectively. Similar pattern was seen for CD4 + CCR3 + and CD4 + CCR4 + expressing cells. Pearson correlation analysis shows no relationship between CCR3 and CCR4 expressions on TCD4 cells (r = 0.211, P = 0.126). The complex expression TH1 (CD4 + CXCR3 + CCR5 + ) receptors determined 1.14% ± 0.54 for control group, 0.86% ± 0.49 for pre-T and 1.57% ± 0.67 for post-T group. Moreover, the TH2 (CD4 + CCR3 + CCR4 + ) expression was 1.60% ± 1.05 for control group, 1.57% ± 0.83 for pre-T and 1.27% ± 0.66 for post-treatment group. Pearson correlation analysis shows that only the CCR3 and CCR5 expression was statistically correlated (r = 0.321, P = 0.018). Conclusion: Due to low expression of CCR5 in TH1 and CCR3 in TH2 cells, it seems that utility of these is extremely limited for clinical evaluation, but not scientific purpose. Moreover, considering the CXCR3 for TH1 cells and CCR4 expression for TH2 cells, due to considerable expression, may be practical.

29 September 2008 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AAAlireza Andalib
Alireza Andalib
SRShokohi Raheleh
Shokohi Raheleh
RARezaei Abbass
Rezaei Abbass
MMMokhtari Mojgan
Mokhtari Mojgan
MMMohageri Mohamadreza
Mohageri Mohamadreza
BSBabazadeh Shadi
Babazadeh Shadi